{"id":"normobaric-oxygen-with-face-mask","safety":{"commonSideEffects":[{"rate":null,"effect":"Oxygen toxicity (with prolonged high-concentration exposure)"},{"rate":null,"effect":"Discomfort or drying of nasal/oral mucosa"},{"rate":null,"effect":"Hyperoxia-related complications"}]},"_chembl":{"chemblId":"CHEMBL1234886","moleculeType":"Small molecule","molecularWeight":"32.00"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Normobaric oxygen (oxygen delivered at normal atmospheric pressure via face mask) increases the dissolved oxygen content in blood plasma and enhances hemoglobin saturation, improving oxygen delivery to tissues. This mechanism is used to treat hypoxemic conditions and may reduce ischemic injury, inflammation, and support tissue healing in various acute and chronic conditions.","oneSentence":"Normobaric oxygen therapy increases arterial oxygen partial pressure to enhance tissue oxygenation and reduce hypoxia-related pathology.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:23:24.577Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypoxemia and tissue hypoxia (specific indication under investigation in Phase 3 trial not fully specified)"}]},"trialDetails":[{"nctId":"NCT07086742","phase":"NA","title":"Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate","status":"RECRUITING","sponsor":"Pathway Medtech, LLC.","startDate":"2025-09-01","conditions":"Sleep-disordered Breathing (SDB), Sleep Apnea, Sleep Quality","enrollment":36},{"nctId":"NCT05379608","phase":"NA","title":"Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2021-12-10","conditions":"COVID-19, Chronic Heart Failure, Hypertension","enrollment":43},{"nctId":"NCT05039697","phase":"NA","title":"Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset：Longterm Outcome","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-04-22","conditions":"Stroke, Acute, Hypoxia-Ischemia, Brain, ENDOVASCULAR TREATMENT","enrollment":282},{"nctId":"NCT06224426","phase":"NA","title":"Oxygen Concentration Target in Stroke Endovascular Treatment","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-02-01","conditions":"Ischemic Stroke","enrollment":200},{"nctId":"NCT05128422","phase":"NA","title":"Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-10-27","conditions":"Stroke, Endovascular Treatment, Neuroprotection","enrollment":120},{"nctId":"NCT05965193","phase":"PHASE3","title":"Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)","status":"RECRUITING","sponsor":"Ji Xunming,MD,PhD","startDate":"2023-08-17","conditions":"Acute Ischemic Stroke","enrollment":1230},{"nctId":"NCT05965687","phase":"PHASE3","title":"Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)","status":"RECRUITING","sponsor":"Ji Xunming,MD,PhD","startDate":"2023-08-17","conditions":"Acute Ischemic Stroke","enrollment":1230},{"nctId":"NCT05404373","phase":"NA","title":"Treatment Duration on Normobaric Hyperoxia in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2022-06-20","conditions":"Stroke, Acute, Neuroprotection, Endovascular Treatment","enrollment":100},{"nctId":"NCT04681651","phase":"PHASE2","title":"Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2021-04-22","conditions":"Stroke, Acute, Neuroprotection","enrollment":282},{"nctId":"NCT05781880","phase":"NA","title":"Normobaric Hyperoxia Stabilizing Ischemic Penumbra","status":"UNKNOWN","sponsor":"Ji Xunming,MD,PhD","startDate":"2023-03-22","conditions":"Acute Ischemic Stroke","enrollment":78},{"nctId":"NCT03500939","phase":"PHASE2","title":"Penumbral Rescue by Normobaric O2 Administration in Patients With Ischemic Stroke and Target Mismatch ProFile","status":"TERMINATED","sponsor":"University Hospital Tuebingen","startDate":"2019-08-01","conditions":"Acute Ischemic Stroke","enrollment":223},{"nctId":"NCT04725851","phase":"NA","title":"High Concentration Oxygen for Pneumocephalus After Evacuation of Chronic Subdural Haematoma","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2022-07-26","conditions":"Chronic Subdural Hematoma, Recurrence, Oxycephaly","enrollment":36},{"nctId":"NCT05053672","phase":"NA","title":"ReOxy Therapy in the Rehabilitation of Chronic Low Back Pain Patients With Comorbidity","status":"COMPLETED","sponsor":"Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine","startDate":"2021-06-01","conditions":"Low Back Pain","enrollment":90},{"nctId":"NCT04791397","phase":"NA","title":"Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2019-04-10","conditions":"Vascular Stiffness, Liver Fibroses, Metabolic Syndrome","enrollment":62},{"nctId":"NCT03506607","phase":"NA","title":"Hypoxic Exercise in Lower Extremity Artery Disease","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2020-01-23","conditions":"Peripheral Arterial Disease","enrollment":20},{"nctId":"NCT03745092","phase":"NA","title":"The Efficacy of Normobaric Oxygen on Chronic Cerebral Ischemia","status":"COMPLETED","sponsor":"Capital Medical University","startDate":"2018-12-01","conditions":"Normobaric Oxygen, Cerebral Ischemia","enrollment":49},{"nctId":"NCT02302027","phase":"NA","title":"Feasibility Study of Normobaric Oxygen Delivered by a High Flow Concentrator in the Treatment of Chronic Headache","status":"UNKNOWN","sponsor":"Association pour la Recherche au Centre d'Urgence des Céphalées","startDate":"2014-12","conditions":"Chronic Headache","enrollment":30},{"nctId":"NCT02439866","phase":"PHASE3","title":"Outcomes of Steroid and Oxygen Therapy Versus Placebo Therapy in Non-arteritic Anterior Ischemic Optic Neuropathy","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2014-02","conditions":"NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)","enrollment":90},{"nctId":"NCT01100515","phase":"PHASE3","title":"Hyperbaric Oxygen Therapy for Acute Domestic Carbon Monoxide (CO) Poisoning","status":"TERMINATED","sponsor":"University of Versailles","startDate":"1989-10","conditions":"Carbon Monoxide Poisoning","enrollment":179},{"nctId":"NCT01099995","phase":"PHASE3","title":"Hyperbaric Oxygen Therapy for Comatose Patients With Acute Carbon Monoxide Poisoning","status":"TERMINATED","sponsor":"University of Versailles","startDate":"1989-10","conditions":"Carbon Monoxide Poisoning","enrollment":170}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"normobaric oxygen with face mask","genericName":"normobaric oxygen with face mask","companyName":"Shahid Beheshti University of Medical Sciences","companyId":"shahid-beheshti-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Normobaric oxygen therapy increases arterial oxygen partial pressure to enhance tissue oxygenation and reduce hypoxia-related pathology. Used for Hypoxemia and tissue hypoxia (specific indication under investigation in Phase 3 trial not fully specified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}